Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001691
Filing Date
2025-03-31
Accepted
2025-03-31 16:04:47
Documents
79
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2584983
2 ex4-2.htm EX-4.2 50716
3 ex19-1.htm EX-19.1 92594
4 ex23-1.htm EX-23.1 3038
5 ex31-1.htm EX-31.1 19452
6 ex31-2.htm EX-31.2 20107
7 ex32-1.htm EX-32.1 8232
8 ex97-1.htm EX-97.1 41156
9 form10-k_007.jpg GRAPHIC 99719
  Complete submission text file 0001641172-25-001691.txt   9148342

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE fblg-20241231.xsd EX-101.SCH 50548
11 XBRL CALCULATION FILE fblg-20241231_cal.xml EX-101.CAL 68998
12 XBRL DEFINITION FILE fblg-20241231_def.xml EX-101.DEF 242235
13 XBRL LABEL FILE fblg-20241231_lab.xml EX-101.LAB 470518
14 XBRL PRESENTATION FILE fblg-20241231_pre.xml EX-101.PRE 388702
82 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1108386
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41934 | Film No.: 25793091
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)